Send feedback

APRT p.Arg145Ser

c.433C>A · rs550667813 · VCV887873

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.2066 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00133%, afr)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
adenine phosphoribosyltransferase deficiency

Computational evidence

Protein change
AlphaMissense0.2066likely benign
REVEL0.368indeterminate
SaProtLLR -7.19tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 5.4GERP 1.6, phastCons 1
Regional constrainto/e 1.26unconstrained · MANE · 2,198 bp · p 5.8e-05 · regional, not allelic
Overall
CADD16.96PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00133% African / African-American · 1/74,932 alleles
Filtering AF 7.9e-05% ClinGen BA1/BS1 input FAF95, joint · FAF99 5.4e-05%
Overall 0.0018% 29/1,612,760 alleles · very rare
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.035% 2,854
Remaining individualsnot grpmax-eligible 0.0032% 31,233
African / African-Americangrpmax 0.00133% 74,932
European (non-Finnish) 0.000339% 295,002

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
APRT
Protein
p.Arg145Ser
Coding
c.433C>A
MANE Select
NM_000485
dbSNP
rs550667813
Type
single nucleotide variant
Location
chr16:88809808 (GRCh38)
Gene constraint
LOEUF 1.789 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 96.91 · 16 PDB
Residue 145
an α-helix
Full APRT gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

adenine phosphoribosyltransferase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Adenine phosphoribosyltransferase deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
Adolescent, Adult, Childhood, Elderly, Infancy
Prevalence
1-9 / 100 000 (Specific population)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/aprt-p-arg145ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown